Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03394742
Other study ID # Effectiveness of peer support
Secondary ID
Status Completed
Phase N/A
First received December 20, 2017
Last updated January 3, 2018
Start date May 1, 2014
Est. completion date October 30, 2016

Study information

Verified date January 2018
Source University of Jyvaskyla
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study examines effectiveness of peer support of breast cancer patients. Half of the participants received peer support via telephone in addition to usual care and another half are give the usual care only.


Description:

Seriously sick people need social support to maintain their quality of life. Social support may be given by peers, who have experienced the same.

In this study voluntary participants with recently diagnosed breast cancer were randomly allocated to intervention (N=130) or control (N=130) group. The intervention group received, in addition to usual care, peer support via telephone 1-5 times according to their own preference. The control group received usual care only. Peer support was given by volunteered breast cancer survivors who were educated for giving peer support.


Recruitment information / eligibility

Status Completed
Enrollment 260
Est. completion date October 30, 2016
Est. primary completion date June 30, 2015
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- recently diagnosed primary breast cancer

- no other serious illnesses

- ability to communicate in Finnish or Swedish (official languages in Finland)

- ability to fill in the questionnaires

Exclusion Criteria:

- some other serious illnesses

- inability to communicate in Finnish or Swedish (official languages in Finland)

- inability to fill in the questionnaires

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Peer support
Peer support persons are breast cancer survivors, who were educated to give peer support. They contacted participants by telephone.

Locations

Country Name City State
Finland Helsinki University Hospital Helsinki

Sponsors (2)

Lead Sponsor Collaborator
University of Jyvaskyla Helsinki University Central Hospital

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Primary A change of health-related quality of life (HRQoL). HRQoL was assessed with a generic 15D instrument. From baseline to 3, 6 and 12 months later.
Primary A change of health-related quality of life (HRQoL). HRQoL was assessed with a disease-specific instrument EORTC QLQ-30 and its breast cancer specific module BR23. From baseline to 3, 6 and 12 months later.
Secondary Satisfaction for life Satisfaction for life was assessed with a questionnaire created for this study. Baseline and 3, 6 and 12 months later.
Secondary The use of health care services The use of health care services was assessed with a questionnaire create for this study. Baseline and 3, 6 and 12 months later.
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Recruiting NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A